# Study of Efficacy and Safety of GNR-060 vs Metalyse in Patients With ST Elevation Myocardial Infarction

Study · id `cardio:ct-nct05601999` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05601999](<https://clinicaltrials.gov/study/NCT05601999>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05601999

Browse, organ or system: Heart; Brain  
Browse, condition area: Coronary and vascular disease; Stroke; Acute care and long-term living  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 244 participants.

## Technical summary

Registry record NCT05601999. Randomized; double masking; primary purpose treatment. Start 2021-09-03 (actual); primary completion 2024-05-06 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 244 participants (enrolled count; ClinicalTrials.gov record NCT05601999, source copy `cardio:ctgov-nct05601999-2026-09-21`, retrieved 2026-10-26)
- Started: 2021-09-03 (actual) (ClinicalTrials.gov record NCT05601999, source copy `cardio:ctgov-nct05601999-2026-09-21`, retrieved 2026-10-26)
- Primary completion: 2024-05-06 (actual) (ClinicalTrials.gov record NCT05601999, source copy `cardio:ctgov-nct05601999-2026-09-21`, retrieved 2026-10-26)
- Completion: 2025-01-15 (actual) (ClinicalTrials.gov record NCT05601999, source copy `cardio:ctgov-nct05601999-2026-09-21`, retrieved 2026-10-26)
- Countries: Russia (ClinicalTrials.gov record NCT05601999, source copy `cardio:ctgov-nct05601999-2026-09-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05601999-2026-09-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study of Efficacy and Safety of GNR-060 vs Metalyse in Patients With ST Elevation Myocardial Infarction
- Condition: ST Elevation Myocardial Infarction
- Intervention (Biological): GNR-060
- Intervention (Biological): Metalyse
- Lead sponsor: AO GENERIUM
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: AO GENERIUM (`cardio:org-ao-generium`)

## Provenance

Content hash: 2c64665f98b65859f7b9ad348819aeb82d0a0042987e301cf53723207a18ec79
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
